Tuesday 16th August 2011
|Text too small?|
Goldman Sachs has cut Newcrest (NCM.AU) to Hold from Buy, while lowering its price target to A$48 from A$52 because the fiscal 2011 results and outlook statements have resulted in material downgrades.
"We still favor exposure to Newcrest for risk diversification," says the broker. "However, we now have a lower EPS forecast for fiscal 2012 than fiscal 2011. Whilst we like the fundamental outlook, we do not believe that the market will look beyond this fall in fiscal 2012 to the real production growth from fiscal 2013 and thus do not see Newcrest outperforming the market during that period."
Goldman Sachs says NCM’s net profit of A$908 million compared to its A$913.6 million expectation, and it was buoyed by a 20 cent special dividend, while cash flow and net debt were slightly worse than expected.
NCM has completed the acquisition of Lihir Gold and while the Papua New Guinea gold assets of Lihir raise the operational risk NCM is still the premier gold stock on the ASX. NCM expects to exceed the original goal of $85 million in cost savings a year from the Lihir acquisition with the balance to focus on maintenance, stores, inventories and mining.
Contact IRG on 0800 437 8489
**A disclosure statement is available, on request and free of charge.
Recommendation sourced from the IRESS software trading platform
In accordance with the Financial Advisers Act 2008 (“the Act”) Sharechat is “Class Advice” and any advice or recommendations contained on this webpage is not “Personalised Advice” as defined by the Act. This means Sharechat does not take into account an investor’s particular financial position, financial needs, financial goals or risk profile. Investor’s who require “Personalised Advice” should contact an Authorised Financial Adviser (AFA).
No comments yet
New Zealand Rural Land Company Limited (NZX: NZL) Agreement to acquire large scale dairy asset portfolio
EROAD Limited (NZX: ERD) launches Clarity Solo Dashcam
22nd October 2021 Morning Report
Pictor ready to roll out game-changing COVID antibody test in New Zealand
Scott Technology Limited (NZX: SCT) Announces FY21 Results
21st October 2021 Morning Report
Greenfern Industries Limited (NZX: GFI) L&Q Notice
TruScreen Group Limited (NZX: TRU) Clinical Trial Results Highlight Efficacy of TRU Technology
20th October 2021 Morning Report
Freightways Limited (NZX: FRE) Acquisition of ProducePronto